Pharmaceutical - Sun Pharmaceutical Industries


Popular Filters

Sun Pharma sets up JV with Intrexon for ocular diseases


Sun Pharmaceutical Industries and Intrexon Corp have formed a joint venture to develop controllable gene-based…

IntrexonPharmaceuticalResearchSun Pharmaceutical Industries

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent


Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Briefs: Depomed drops Sefelsa after CRL: Sun Pharma stalking Meda?


US specialty drugmaker Depomed (Nasdaq: DEPO) says that Food and Drug Administration issued a complete…

DepomedMedaMergers & AcquisitionsMetabolicsNorth AmericaPharmaceuticalRegulationResearchSefelsaSun Pharmaceutical Industries

Sun Pharma gives up fight to take full control of Taro; Angel Biotech in administration


Israel-based Taro Pharmaceutical Industries (Pink Sheets: TAROF) and Indian drugmaker Sun Pharmaceutical…

Angel BiomedicalAngel BiotechnologyBiotechnologyFinancialMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million


India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers


The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

US FDA acts on cancer drugs shortages; move applauded by GPhA


The US Food and Drug Administration this week spelt out a series of steps to increase the supply of critically…

APP PharmaceuticalsDoxilGenericsHospiraMarkets & MarketingmethotrexateNorth AmericaOncologyPharmaceuticalRegulationSun Pharmaceutical Industries

Back to top